Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of K-757 in healthy overweight/obese volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• K-757

Snippet

Sponsor: Kallyope Inc. | Conditions: Obesity | Phase 1 | Status: COMPLETED